John Deanfield - Researcher Profile | RDL Research Database

Publications

4 shown

Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people

Eleni Rapsomaniki , Adam Timmis , Julie George +10 more

2014 The Lancet 1581 citations

Trends in hospital treatments, including revascularisation, following acute myocardial infarction, 2003–2010: a multilevel and relative survival analysis for the National Institute for Cardiovascular Outcomes Research (NICOR)

Chris P Gale , Victoria Allan , Brian A. Cattle +7 more

Survival rates after AMI have improved. Whereas survival estimates for STEMI patients who did not receive reperfusion therapy were stable, they worsened for NSTEMI patients not ...

2014 Heart 98 citations

Atherosclerosis

Peter Libby , Julie E. Buring , Lina Badimón +5 more

2019 Nature Reviews Disease Primers 2698 citations

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

A. Michael Lincoff , Kirstine Brown‐Frandsen , Helen M. Colhoun +13 more

In patients with preexisting cardiovascular disease and overweight or obesity but without diabetes, weekly subcutaneous semaglutide at a dose of 2.4 mg was superior to placebo i...

2023 New England Journal of Medicine 1860 citations

Frequent Co-Authors

Researcher Info

h-index: 4
Publications: 4
Citations: 6,237
Institution: Farr Institute

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-8806-6052

Impact Metrics

h-index 4

h-index: Number of publications with at least h citations each.